[Use of thymalin in the complex treatment of patients with cancer of the uterus].
The results of a clinico-immunologic study of thymalin as a component of complex antitumor treatment of 21 cases of cancer of corpus uteri pointed to a pronounced immunomodulating action of the drug on T-cell-mediated immunity. It was inferred that thymalin should be used for immunocorrection in complex treatment for the said neoplasms provided T-cell-mediated immunity is monitored.